These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28614005)

  • 21. Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
    Charmandari E; Vlachopapadopoulou E; Kyritsi EM; Sakellariou D; Koledova E; Nespithal K; Michalacos S
    Growth Horm IGF Res; 2020; 53-54():101336. PubMed ID: 32739654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal analysis of T-helper cell phenotypes in renal-transplant recipients undergoing growth hormone therapy.
    Melk A; Daniel V; Mehls O; Opelz G; Tönshoff B
    Transplantation; 2004 Dec; 78(12):1792-801. PubMed ID: 15614153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.
    Mehls O; Lindberg A; Haffner D; Schaefer F; Wühl E; ;
    Pediatr Nephrol; 2015 Dec; 30(12):2145-51. PubMed ID: 26198275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translating clinical guidelines into practice: the effective and appropriate use of human growth hormone.
    Navarro R; Dunn JD; Lee PA; Owens GM; Rapaport R
    Am J Manag Care; 2013 Nov; 19(15 Suppl):s281-9. PubMed ID: 24494610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of recombinant human growth hormone in children with thalassemia.
    Geffner ME; Karlsson H
    Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
    Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term response to recombinant human growth hormone treatment: a new predictive mathematical method.
    Migliaretti G; Ditaranto S; Guiot C; Vannelli S; Matarazzo P; Cappello N; Stura I; Cavallo F
    J Endocrinol Invest; 2018 Jul; 41(7):839-848. PubMed ID: 29318462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
    Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
    J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics.
    Albertsson-Wikland K; Mårtensson A; Sävendahl L; Niklasson A; Bang P; Dahlgren J; Gustafsson J; Kriström B; Norgren S; Pehrsson NG; Odén A
    J Clin Endocrinol Metab; 2016 May; 101(5):2149-59. PubMed ID: 26918292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term adherence to growth hormone therapy in a large health maintenance organization cohort.
    Farfel A; Shalitin S; Morag N; Meyerovitch J
    Growth Horm IGF Res; 2019 Feb; 44():1-5. PubMed ID: 30414995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consequences of brand switches during the course of pediatric growth hormone treatment.
    Grimberg A; Feudtner C; Gordon CM
    Endocr Pract; 2012; 18(3):307-16. PubMed ID: 21940275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of growth hormone in children and adolescents].
    Bergadá I
    Medicina (B Aires); 2013; 73(3):272-6. PubMed ID: 23732208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human growth hormone for treating burns and donor sites.
    Breederveld RS; Tuinebreijer WE
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008990. PubMed ID: 23235668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.